Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-20

FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Cadila Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Cadila Pharmaceuticals Limited's supplemental application for donepezil hydrochloride, a drug used to treat Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donepezil hydrochloride (Donepezil hydrochloride)

Snippet

SUPPL AP for DONEPEZIL HYDROCHLORIDE (DONEPEZIL HYDROCHLORIDE)